24.24
0.08%
+0.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CSTL Giù?
Forum
Previsione
Castle Biosciences Inc Borsa (CSTL) Ultime notizie
Castle Biosciences CEO Derek Maetzold sells $153k in company stock - Investing.com
Investing.com
Castle Biosciences CEO Derek Maetzold sells $153k in company stock - Investing.com India
Investing.com India
Omega Therapeutics, Inc. (OMGA) Surges 19.6%: Is This an Indication of Further Gains? - Yahoo Movies UK
Yahoo Movies UK
Castle Biosciences Inc [CSTL] Investment Appeal on the Rise – Knox Daily - Knox Daily
Knox Daily
Castle Biosciences to Present at the Leerink Partners Healthcare Crossroads Conference - Yahoo Canada Finance
Yahoo Canada Finance
Castle Biosciences Expands Evidence Supporting the Performance of its TissueCypher® Barrett's Esophagus Test in ... - Yahoo Finance
Yahoo Finance
Castle Biosciences' IDgenetix ® Test Receives 2024 MedTech Breakthrough Award for Best Overall Mental Health ... - Investing.com India
Investing.com India
Castle Biosciences' IDgenetix® Test Receives 2024 MedTech Breakthrough Award for “Best Overall Mental Health ... - Business Wire
Business Wire
Castle Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase ... - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Movies UK
Yahoo Movies UK
Derek J. Maetzold Sells 2,368 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) Stock - MarketBeat
MarketBeat
Castle Biosciences CEO sells over $150000 in company stock - Investing.com South Africa
Investing.com South Africa
Castle Biosciences director sells over $570k in company stock - Investing.com India
Investing.com India
Castle Biosciences director sells over $570k in company stock - Investing.com Canada
Investing.com Canada
Castle Biosciences CEO sells over $150000 in company stock - Investing.com
Investing.com
Castle Biosciences director sells over $570k in company stock - Investing.com
Investing.com
Castle Biosciences director sells over $570k in company stock - Investing.com UK
Investing.com UK
Zurcher Kantonalbank Zurich Cantonalbank Boosts Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World
Defense World
Castle Biosciences CEO sells over $150000 in company stock - Investing.com
Investing.com
Wall Street Analysts Predict a 36.09% Upside in Castle Biosciences (CSTL): Here's What You Should Know - Yahoo Finance
Yahoo Finance
Castle Biosciences (CSTL) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Yahoo Finance
Earnings Beat: Castle Biosciences, Inc. (NASDAQ:CSTL) Just Beat Analyst Forecasts, And Analysts Have Been Lifting ... - Yahoo Finance
Yahoo Finance
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Castle Biosciences First Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Simply Wall St
Castle Biosciences (NASDAQ:CSTL) Price Target Raised to $34.00 - MarketBeat
MarketBeat
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates - Zacks Investment Research
Zacks Investment Research
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Yahoo Finance
Castle Biosciences Reports First Quarter 2024 Results - Business Wire
Business Wire
Castle Biosciences Inc (CSTL) Q1 2024 Earnings: Surpasses Revenue Forecasts and Raises Annual ... - Yahoo Finance
Yahoo Finance
Castle Biosciences Kicks off Skin Cancer Awareness Month with a Ribbon Cutting to Celebrate the City of ... - Business Wire
Business Wire
Castle Biosciences (NASDAQ:CSTL) Trading Up 6.3% - MarketBeat
MarketBeat
Castle Biosciences CEO Derek Maetzold sells shares worth over $22,000 By Investing.com - Investing.com
Investing.com
Castle Biosciences (CSTL) Set to Announce Earnings on Thursday - Defense World
Defense World
Castle Biosciences' Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive ... - citybiz
citybiz
Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations - Yahoo Finance
Yahoo Finance
Castle Biosciences CEO Derek Maetzold sells shares worth over $137k - Investing.com Canada
Investing.com Canada
Presentations at EADO Highlight Potential Impact of Castle Biosciences' DecisionDx®-Melanoma and DecisionDx ... - Business Wire
Business Wire
Castle Biosciences Secures Loan and Reshuffles Board - TipRanks.com - TipRanks
TipRanks
Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year - Yahoo Finance
Yahoo Finance
New Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences' IDgenetix ... - Yahoo Finance
Yahoo Finance
Castle Biosciences to Present New Data Highlighting the Clinical Value of its Dermatologic Tests for Patients with Skin ... - Business Wire
Business Wire
Castle Biosciences, Inc. (NASDAQ:CSTL) Reported Earnings Last Week And Analysts Are Already Upgrading Their ... - Yahoo Finance
Yahoo Finance
Castle Biosciences Full Year 2023 Earnings: Beats Expectations - Yahoo Finance
Yahoo Finance
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2023 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Castle Biosciences, Inc. (CSTL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research
Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
Castle Biosciences Inc (CSTL) Reports Robust Revenue Growth and Improved Margins in 2023 - Yahoo Finance
Yahoo Finance
Insights Into Castle Biosciences, Inc. (CSTL) Q4: Wall Street Projections for Key Metrics
Zacks Investment Research
Capitalizzazione:
|
Volume (24 ore):